Comparative efficacy of an indigenous 'inactivated vaccine' using highly pathogenic field strain of Mycobacterium avium subspecies paratuberculosis 'Bison type' with a commercial vaccine for the control of Capri-paratuberculosis in India
- PMID: 17804124
- DOI: 10.1016/j.vaccine.2007.07.054
Comparative efficacy of an indigenous 'inactivated vaccine' using highly pathogenic field strain of Mycobacterium avium subspecies paratuberculosis 'Bison type' with a commercial vaccine for the control of Capri-paratuberculosis in India
Abstract
Johne's disease (JD) is endemic in goatherds located at Central Institute for Research on Goats, Makhdoom, since 1979 and lately it has been reported from farmer's herds in equal frequencies. Despite using test and slaughter method for the control of JD for more than 25 years in these herds, incidence of JD has not been reduced. Efficacy of 'indigenous vaccine' containing native 'Bison type' genotype of Mycobacterium avium subspecies paratuberculosis (MAP) was compared with commercial vaccine using challenge studies with homologous strain of MAP. Goat kids (85) were randomly divided in to three groups. Kids were vaccinated with 1 ml of vaccine subcutaneously and Sham-immunized with 1 ml of sterile PBS. All kids except 3 in each group were challenged twice at 75- and 275-day post-vaccination (DPV). Four goats each from three groups were sacrificed at 200-day post-challenge to evaluate carcass and histopathologically for vaccine and challenge response in kids of different groups. Samples (blood, serum and fecal) were screened for LTT, ELISA and shedding of bacilli and data on live animal traits, mortality and experimental sacrifice were compared. Average body weights gained by goats in three groups at different stages of trials (0, 1-75, 76-275, 276-425 DPV) showed marked improvements in performance of vaccinated groups over 'Sham-immunized' group. Effect of vaccines against challenge became visible in terms of body weights gained at 276-425 DPV ('Bison' group gained significantly higher body weights than 'Sham-immunized'). Mortality was significantly less in two vaccinated as compared to 'Sham-immunized'. Vaccinated groups also had significant stimulation and sero-conversion for cell mediated and humoral immune response, respectively as compared to 'Sham-immunized'. Results of post-challenged fecal culture showed significant reduction in shedding of MAP in both vaccinated groups than in 'Sham-immunized'. There was significant improvement in external and internal body traits and histological lesions in case of vaccinated than 'Sham-immunized' group.
Similar articles
-
Efficacy of spheroplastic and cell-wall competent vaccines for Mycobacterium avium subsp. paratuberculosis in experimentally-challenged baby goats.Vet Microbiol. 2007 Mar 10;120(3-4):261-83. doi: 10.1016/j.vetmic.2006.10.030. Epub 2006 Oct 29. Vet Microbiol. 2007. PMID: 17123751
-
Sero-prevalence of bovine Johne's disease in buffaloes and cattle population of North India using indigenous ELISA kit based on native Mycobacterium avium subspecies paratuberculosis 'Bison type' genotype of goat origin.Comp Immunol Microbiol Infect Dis. 2008 Sep;31(5):419-33. doi: 10.1016/j.cimid.2007.06.002. Epub 2007 Sep 12. Comp Immunol Microbiol Infect Dis. 2008. PMID: 17854892
-
Efficacy of 'indigenous vaccine' using native 'Indian bison type' genotype of Mycobacterium avium subspecies paratuberculosis for the control of clinical Johne's disease in an organized goat herd.Vet Res Commun. 2013 Jun;37(2):109-14. doi: 10.1007/s11259-013-9551-4. Epub 2013 Jan 24. Vet Res Commun. 2013. PMID: 23345101 Clinical Trial.
-
Vaccination against paratuberculosis.Expert Rev Vaccines. 2008 Aug;7(6):817-32. doi: 10.1586/14760584.7.6.817. Expert Rev Vaccines. 2008. PMID: 18665779 Review.
-
Vaccine approaches for the 'therapeutic management' of Mycobacterium avium subspecies paratuberculosis infection in domestic livestock.Vet Q. 2019 Dec;39(1):143-152. doi: 10.1080/01652176.2019.1667042. Vet Q. 2019. PMID: 31524561 Free PMC article. Review.
Cited by
-
Assessment of live candidate vaccines for paratuberculosis in animal models and macrophages.Infect Immun. 2010 Mar;78(3):1383-9. doi: 10.1128/IAI.01020-09. Epub 2009 Dec 28. Infect Immun. 2010. PMID: 20038535 Free PMC article.
-
Therapeutic Effects of a New "Indigenous Vaccine" Developed Using Novel Native "Indian Bison Type" Genotype of Mycobacterium avium Subspecies paratuberculosis for the Control of Clinical Johne's Disease in Naturally Infected Goatherds in India.Vet Med Int. 2010;2010:351846. doi: 10.4061/2010/351846. Epub 2010 Feb 14. Vet Med Int. 2010. PMID: 20445782 Free PMC article.
-
Preliminary Results Indicate That Inactivated Vaccine against Paratuberculosis Could Modify the Course of Experimental Mycobacterium bovis Infection in Calves.Front Vet Sci. 2017 Oct 18;4:175. doi: 10.3389/fvets.2017.00175. eCollection 2017. Front Vet Sci. 2017. PMID: 29094040 Free PMC article.
-
Genomic variations associated with attenuation in Mycobacterium avium subsp. paratuberculosis vaccine strains.BMC Microbiol. 2013 Jan 22;13:11. doi: 10.1186/1471-2180-13-11. BMC Microbiol. 2013. PMID: 23339684 Free PMC article.
-
Immuno-reactivity evaluation of Mce-truncated subunit candidate vaccine against Mycobacterium avium subspecies paratuberculosis challenge in the goat models.BMC Vet Res. 2023 Sep 14;19(1):157. doi: 10.1186/s12917-023-03715-z. BMC Vet Res. 2023. PMID: 37710242 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources